search

1-20 of 65

Save search

Sort by

Sort Order Select

2 3 4

Journal Article

P-1258. Unlocking Potentials: The Impact of Meropenem, Meropenem-vaborbactam, and Ceftazidime-avibactam in Combatting Carbapenem-Resistant Enterobacter cloacae in Epithelial Lining Fluid and Serum

PDF

Thomas Lavoie and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1440, https://doi.org/10.1093/ofid/ofae631.1440

Published: 29 January 2025

Journal Article

312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF

Michael P Veve and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.102, https://doi.org/10.1093/ofid/ofae631.102

Published: 29 January 2025

Journal Article

P-639. Development of antimicrobial resistance in patients with pneumonia due to P.aeruginosa treated with cefepime or piperacillin-tazobactam

PDF

Raneem H Pallotta and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.836, https://doi.org/10.1093/ofid/ofae631.836

Published: 29 January 2025

Journal Article

P-1105. Effectiveness of Imipenem-Relebactam for Multidrug-resistant Pseudomonas aeruginosa in Pneumonia and Bloodstream Infections in the United States (MIRAGE)

PDF

Walaiporn Wangchinda and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1293, https://doi.org/10.1093/ofid/ofae631.1293

Published: 29 January 2025

Journal Article

P-1697. Antibiotic prescribing patterns among outpatients with acute sinusitis in Michigan

PDF

Walaiporn Wangchinda and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1863, https://doi.org/10.1093/ofid/ofae631.1863

Published: 29 January 2025

Journal Article

311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF

jason M Pogue and others

Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.101, https://doi.org/10.1093/ofid/ofae631.101

Published: 29 January 2025

Journal Article

EDITOR'S CHOICE

A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors

PDF

Walaiporn Wangchinda and others

Open Forum Infectious Diseases, Volume 11, Issue 11, November 2024, ofae643, https://doi.org/10.1093/ofid/ofae643

Published: 30 October 2024

Supplementary data

Journal Article

Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?

PDF

Jason M Pogue and Samuel L Aitken

Open Forum Infectious Diseases, Volume 11, Issue 1, January 2024, ofad645, https://doi.org/10.1093/ofid/ofad645

Published: 18 December 2023

Journal Article

1764. Collaboration between Public Health and Healthcare Partners to Attack the Rising Menace of Candida auris: The Michigan Experience

PDF

Brenda M Brennan and others

Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1595, https://doi.org/10.1093/ofid/ofad500.1595